Similar articles

• Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature.

  Ansara AJ, Nisly SA, Arif SA, Koehler JM, Nordmeyer ST. Ansara AJ, et al. Ann Pharmacother. 2010 May;44(5):851-62. doi: 10.1345/aph.1M346. Epub 2010 Apr 13. Ann Pharmacother. 2010. PMID: 20388864 Review.
• Newer antiplatelet therapies in stroke prevention.

  Davis SM, Donnan GA. Davis SM, et al. Aust Fam Physician. 2001 Feb;30(2):129-34. Aust Fam Physician. 2001. PMID: 11280112
• Aspirin in stroke prevention in nonvalvular atrial fibrillation and stable vascular disease: an era of new anticoagulants.

  Turagam MK, Velagapudi P, Leal MA, Kocheril AG. Turagam MK, et al. Expert Rev Cardiovasc Ther. 2012 Apr;10(4):433-9. doi: 10.1586/erc.12.19. Expert Rev Cardiovasc Ther. 2012. PMID: 22458577 Review.
• Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

  Kirshner HS. Kirshner HS. Int J Clin Pract. 2007 Oct;61(10):1739-48. doi: 10.1111/j.1742-1241.2007.01515.x. Int J Clin Pract. 2007. PMID: 17877660 Review.
• Ticlopidine versus aspirin for stroke prevention: On-treatment results from the ticlopidine aspirin stroke study.

  Ticlopidine Aspirin Stroke Study Group. Ticlopidine Aspirin Stroke Study Group. J Stroke Cerebrovasc Dis. 1993;3(3):168-76. doi: 10.1016/S1052-3057(10)80157-0. Epub 2010 Jun 9. J Stroke Cerebrovasc Dis. 1993. PMID: 26487357